World's Best Scientists 2026 revealed!
Vera J. Suman

Vera J. Suman

D-Index & Metrics

Medicine

D-Index
91
Citations
56122
World Ranking
11498
National Ranking
5893

Overview

Vera J. Suman is affiliated with the Mayo Clinic in the United States and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses extensively on Oncology and Cancer Research, with additional contributions in Pulmonary and Respiratory Medicine and Genetics.

The main areas of study covered by Suman include Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Estrogen and related hormone effects, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics, Multiple Myeloma Research and Treatments, and HER2/EGFR in Cancer Research.

Suman has published extensively in several scientific outlets. Frequent publication venues feature:

  • Cancer Research
  • Clinical Cancer Research
  • Journal of Clinical Oncology
  • UNC Libraries
  • Breast Cancer Research

Some recent notable papers authored or co-authored by Suman include:

  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, The Lancet Oncology
  • Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials, 2023, The Lancet
  • Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer, 2024, JAMA
  • FOXA1 overexpression suppresses interferon signaling and immune response in cancer, 2021, Journal of Clinical Investigation
  • Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic, 2020, npj Breast Cancer

Suman frequently collaborates with a number of other researchers in the oncology field. Some frequent co-authors include:

  • Matthew P. Goetz
  • Krishna R. Kalari
  • Judy C. Boughey
  • Liewei Wang
  • James N. Ingle

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

    Edward H. Romond;Edith A. Perez;John Bryant;Vera J. Suman

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

    Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt

  • Benign breast disease and the risk of breast cancer

    Lynn C. Hartmann;Thomas A. Sellers;Marlene H. Frost;Wilma L. Lingle

  • Whole-genome analysis informs breast cancer response to aromatase inhibition

    Matthew J. Ellis;Li Ding;Dong Shen;Jingqin Luo

  • Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

    Edith A. Perez;Edward H. Romond;Vera J. Suman;Jong Hyeon Jeong

  • Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

    Matthew P. Goetz;James M. Rae;Vera J. Suman;Stephanie L. Safgren

  • Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

    Edith A. Perez;Edward H. Romond;Vera J. Suman;Jong Hyeon Jeong

  • Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

    Edward L. Korn;Ping Yu Liu;Sandra J. Lee;Judith Anne W. Chapman

  • Meningioma grading: an analysis of histologic parameters.

    Arie Perry;Scott L. Stafford;Bernd W. Scheithauer;Vera J. Suman

  • Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

    Edith A. Perez;Vera J. Suman;Nancy E. Davidson;George W. Sledge

  • The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen.

    Matthew P. Goetz;Stacey K. Knox;Vera J. Suman;James M. Rae

  • Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

    Matthew J. Ellis;Vera J. Suman;Jeremy Hoog;Li Lin

  • Incidence of Alopecia Areata in Olmsted County, Minnesota, 1975 Through 1989

    Kayvon H. Safavi;Sigfrid A. Muller;Vera J. Suman;Alan N. Moshell

  • Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

    Werner Schroth;Matthew P. Goetz;Ute Hamann;Peter A. Fasching;Peter A. Fasching

  • Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

    Keith C Bible;Vera J Suman;Julian R Molina;Robert C Smallridge

  • Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831

    Patrick C. Roche;Vera J. Suman;Robert B. Jenkins;Nancy E. Davidson

  • HER2 Testing by Local, Central, and Reference Laboratories in Specimens From the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial

    Edith A. Perez;Vera J. Suman;Nancy E. Davidson;Silvana Martino

  • Normal Range of Motion of the Cervical Spine: An Initial Goniometric Study

    James W Youdas;Tom R Garrett;Vera J Suman;Connie L Bogard

Frequent Co-Authors

James N. Ingle
James N. Ingle Mayo Clinic
Matthew P. Goetz
Matthew P. Goetz Mayo Clinic
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Liewei Wang
Liewei Wang Mayo Clinic
Edith A. Perez
Edith A. Perez Mayo Clinic
Judy C. Boughey
Judy C. Boughey Mayo Clinic
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a career in medicine or healthcare but looking for flexible ways to study, online degrees can be a great option. Pursuing advanced nursing roles is possible with cheapest dnp programs online, which help qualified nurses achieve a Doctor of Nursing Practice degree—often at a lower cost than on-campus programs.

For those considering a pharmacy career, pharm d online programs offer pathways to earn a doctorate in pharmacy through remote study. This is ideal for students needing a more flexible schedule without sacrificing the quality of education.

Administration and data management roles in healthcare are also in demand. You can prepare for certification with rhia certification programs online, which provide skills in health information administration. Additionally, billing and coding remains a crucial field, and you can enter it by enrolling in the cheapest medical coding certification online programs to gain the certifications employers seek.

Exploring these online degrees can expand your career options and offer greater flexibility as you pursue your goals in the healthcare industry.

Best Scientists Citing Vera J. Suman

Trending Scientists

Recently Published Articles